2021-01-10,GlycoMimetics (NASDAQ:GLYC) Is In A Good Position To Deliver On Growth Plans
2021-01-07,APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia
2020-12-11,Is GLYC A Good Stock To Buy Now?
2020-12-07,New Supportive Efficacy Data for GlycoMimetics Rivipansel in Sickle Cell Acute Vaso-Occlusive Crisis Presented at 62nd ASH Annual Meeting and Exposition
2020-12-05,"GlycoMimetics Uproleselan in Combination With Venetoclax/HMA Shown to Break Chemoresistance, Reduce Tumor Burden and Increase Survival in AML Model"
2020-11-26,If You Had Bought GlycoMimetics' (NASDAQ:GLYC) Shares Three Years Ago You Would Be Down 73%
2020-11-10,GlycoMimetics to Present at Two Upcoming Virtual Healthcare Investor Conferences
2020-11-06,GlycoMimetics Inc (GLYC) Q3 2020 Earnings Call Transcript
2020-11-06,GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2020
2020-11-06,"GlycoMimetics, Inc. to Host Earnings Call"
2020-11-04,GlycoMimetics Program Data to be Highlighted Via Three Oral Presentations and Two Posters at 62nd American Society of Hematology Annual Meeting and Exposition
2020-10-30,"GlycoMimetics to Report Third Quarter Financial Results on November 6, 2020"
2020-10-26,New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) Meeting
2020-10-12,"Have Insiders Been Buying GlycoMimetics, Inc. (NASDAQ:GLYC) Shares?"
2020-10-06,GlycoMimetics' Rivipansel Gets Rare Pediatric Disease Status
2020-10-06,"The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation"
2020-10-05,FDA Grants GlycoMimetics Rare Pediatric Disease Designation for Rivipansel for Treatment of Sickle Cell Disease
2020-09-08,GlycoMimetics to Present at Upcoming H.C. Wainwright & Co Annual Global Investment Virtual Conference
2020-09-04,GlycoMimetics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2020-08-31,New Preclinical GlycoMimetics Data Suggests Uproleselan With Venetoclax/HMA in AML May Prolong Survival
2020-08-28,How Much Is GlycoMimetics' (NASDAQ:GLYC) CEO Getting Paid?
2020-08-06,3 Strong Buy Healthcare Stocks Under $5 That Could See Outsized Gains
2020-07-31,GlycoMimetics Inc (GLYC) Q2 2020 Earnings Call Transcript
2020-07-31,GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2020
2020-07-24,"GlycoMimetics to Report Second Quarter Financial Results on July 31, 2020"
2020-07-22,Here's Why We're Not Too Worried About GlycoMimetics' (NASDAQ:GLYC) Cash Burn Situation
2020-07-10,GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2020-06-30,"Were Hedge Funds Right About Piling Into GlycoMimetics, Inc. (GLYC)?"
2020-06-30,GlycoMimetics (GLYC) in Focus: Stock Moves 8.1% Higher
2020-06-12,New Efficacy and Biomarker Data From Rivipansel Phase 3 RESET Trial to Be Presented at Sickle Cell Meeting
2020-06-12,How GlycoMimetics (GLYC) Stock Stands Out in a Strong Industry
2020-05-29,GlycoMimetics to Present at Upcoming Jefferies Virtual Healthcare Conference
2020-05-15,GlycoMimetics to Present New Preclinical Data Highlighting Biomarkers and Potential Expanded Pipeline Opportunities at Virtual AACR Annual Meeting 2020
2020-05-12,Edited Transcript of GLYC earnings conference call or presentation 1-May-20 12:30pm GMT
2020-05-08,GlycoMimetics Announces Change to Virtual Meeting Format for 2020 Annual Meeting of Shareholders
2020-05-05,Imagine Owning GlycoMimetics (NASDAQ:GLYC) And Trying To Stomach The 77% Share Price Drop
2020-05-01,GlycoMimetics Inc (GLYC) Q1 2020 Earnings Call Transcript
2020-05-01,GlycoMimetics Reports Operational Highlights and Financial Results for First Quarter 2020
2020-04-30,Compelling Data on Mechanism of Action for GlycoMimetics Late-stage Clinical Candidate Uproleselan Published in Nature Communications
2020-04-24,"GlycoMimetics to Report First Quarter Financial Results on May 1, 2020"
2020-04-07,"GlycoMimetics Appoints Dr. Myra Rosario Herrle as Vice President, Regulatory Affairs"
2020-04-06,GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2020-03-26,Edited Transcript of GLYC earnings conference call or presentation 28-Feb-20 1:30pm GMT
2020-03-11,"Daniel Junius Is The Independent Director of GlycoMimetics, Inc. (NASDAQ:GLYC) And They Just Spent US$68k On Shares"
2020-02-28,GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019
2020-02-25,GlycoMimetics to Present at the Cowen and Company 40th Annual Health Care Conference 2020
2020-02-11,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology"
2020-02-06,Wall Street Pros: These 3 Stocks Can Double Next Year
2020-02-04,GlycoMimetics Advances GMI-1359 Program With Patent Issuance and FDA Designations
2020-01-30,First Patient With Advanced Breast Cancer Receives First Dose in Clinical Trial of GlycoMimetics' GMI-1359
2020-01-06,Intrexon will take the name of its subsidiary. That company just scored orphan status for a rare cancer drug.
2020-01-06,"Md. biotech outlines path for blood cancer drug, including in China"
2020-01-06,GlycoMimetics and Apollomics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Uproleselan and GMI-1687 in Greater China
2019-12-19,"Hedge Funds Dropped The Ball On GlycoMimetics, Inc. (GLYC)"
2019-11-29,GlycoMimetics to Present at the Piper Jaffrey 31st Annual Healthcare Conference 2019
2019-11-15,Edited Transcript of GLYC earnings conference call or presentation 7-Nov-19 1:30pm GMT
2019-11-13,GlycoMimetics to Present at Two Upcoming Investor Conferences
2019-11-08,Pharma Sector Tops in October: Best ETFs & Stocks
2019-11-07,GlycoMimetics Reports Third Quarter 2019 Financial Results and Recent Operational Developments
2019-11-06,GlycoMimetics to Present Further Analysis of Data From Phase 1/2 AML Trial of Uproleselan at 61st ASH Meeting
2019-10-31,"GlycoMimetics to Report Third Quarter 2019 Financial Results on November 7, 2019"
2019-10-30,"GlycoMimetics, Inc. (GLYC) Is Burning These Hedge Funds"
2019-09-19,"GlycoMimetics, Inc.'s (NASDAQ:GLYC) Single Biggest Risk For Investors"
2019-08-27,Edited Transcript of GLYC earnings conference call or presentation 1-Aug-19 12:30pm GMT
2019-08-18,Analysts Recommend These 2 Falling Knives
2019-08-08,Are Options Traders Betting on a Big Move in GlycoMimetics (GLYC) Stock?
2019-08-05,"A Look At Benzinga Pro's Most-Searched Tickers For August 5, 2019"
2019-08-05,GlycoMimetics stock down 53% after Phase 3 trial failure
2019-08-05,GlycoMimetics Plummets After Phase 3 Trial of Sickle Cell Treatment Fails
2019-08-02,GlycoMimetics Reports Top-line Results From Pfizers Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease
2019-08-02,GlycoMimetics (GLYC) Q2 2019 Earnings Call Transcript
2019-07-25,"GlycoMimetics to Report Second Quarter 2019 Financial Results on August 1, 2019"
2019-07-23,GlycoMimetics Enters Oversold Territory
2019-05-29,GlycoMimetics to Present at Jefferies 2019 Healthcare Conference
2019-05-20,Edited Transcript of GLYC earnings conference call or presentation 2-May-19 12:30pm GMT
2019-05-11,"Heres What Hedge Funds Think About GlycoMimetics, Inc. (GLYC)"
2019-05-06,"GlycoMimetics, Inc. Announces Enrollment Completed for Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease"
2019-05-04,GlycoMimetics (GLYC) Q1 2019 Earnings Call Transcript
2019-05-02,GlycoMimetics: 1Q Earnings Snapshot
2019-05-02,GlycoMimetics Reports First Quarter 2019 Results and Recent Operational Highlights
2019-05-02,"GlycoMimetics, Inc. to Host Earnings Call"
2019-04-29,"GlycoMimetics Bolsters Executive Team with Appointment of Dr. Eric Feldman as Vice President, Clinical Development, and Christian Dinneen-Long as Vice President, Corporate Counsel"
2019-04-25,"GlycoMimetics to Report First Quarter 2019 Financial Results on May 2, 2019"
2019-04-23,GlycoMimetics Announces Enrollment of First Patient in NCI-Sponsored Phase 3 Trial of Uproleselan in AML
2019-04-22,GlycoMimetics Announces Publication of Nature Cell Biology Paper Supporting Recently Announced Clinical Trial of GMI-1359
2019-04-21,Edited Transcript of GLYC earnings conference call or presentation 6-Mar-19 1:30pm GMT
2019-04-12,GlycoMimetics Announces Plans to Initiate Breast Cancer Trial to Evaluate GMI-1359
2019-04-04,GlycoMimetics to Present at Upcoming Investor Conferences
2019-03-07,GlycoMimetics to Present at the Cowen and Company 39th Annual Health Care Conference 2019
2019-03-06,"Did GlycoMimetics, Inc. (NASDAQ:GLYC) Insiders Sell Shares?"
2019-03-06,GlycoMimetics Inc (GLYC) Q4 2018 Earnings Conference Call Transcript
2019-03-06,GlycoMimetics Reports Fourth Quarter and Year-End 2018 Results
2019-03-06,"GlycoMimetics, Inc. to Host Earnings Call"
2019-03-05,GlycoMimetics Announces Transition Plan for Board of Directors
2019-02-27,"GlycoMimetics to Report Fourth Quarter and Year-End 2018 Financial Results on March 6, 2019"
2019-02-11,"Detailed Research: Economic Perspectives on Waddell & Reed Financial, Kennametal, Automatic Data Processing, Trustmark, Eagle Bulk Shipping, and GlycoMimetics  What Drives Growth in Today's Competitive Landscape"
2018-12-12,"Heres What We Think About GlycoMimetics, Inc.s (NASDAQ:GLYC) CEO Pay"
2018-12-04,GlycoMimetics Posters at 60th ASH Annual Meeting Highlight Preclinical Data on Two New Proprietary Drug Candidates
2018-12-03,GlycoMimetics Presents New AML Data with Uproleselan at 60th ASH Annual Meeting
2018-11-29,"GlycoMimetics to Host 2018 Investor/Analyst Meeting at 60th ASH Annual Meeting on December 3, 2018"
